C. Andrews

Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer

K. Odunsi, L. Old, P. Shrikant, 2007, Proceedings of the National Academy of Sciences.

Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer.

P. Wallace, R. Cheney, K. Odunsi, 2009, Cancer research.

Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006.

Anurag K. Singh, K. Odunsi, S. McCloskey, 2009, Gynecologic Oncology.

Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer.

K. Odunsi, L. Old, O. Caballero, 2009, Cancer immunity.

Cancer Immunity (26 August 2009) Vol. 9, p. 6

K. Odunsi, L. Old, P. Mhawech-Fauceglia, 2005 .

Monoclonal antibodies directed against preneoplastic and neoplastic murine mammary lesions.

W. Wei, R. Barth, S. Tuttle, 1985, Cancer research.

Seromic profiling of ovarian and pancreatic cancer

N. Halama, D. Jäger, M. Büchler, 2010, Proceedings of the National Academy of Sciences.

14-3-3sigma expression and prognostic value in patients with epithelial ovarian carcinoma: a high throughput tissue microarray analysis.

F. Herrmann, K. Odunsi, P. Mhawech-Fauceglia, 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Elevated Expression of the Serine-Arginine Protein Kinase 1 Gene in Ovarian Cancer and Its Role in Cisplatin Cytotoxicity In Vitro

K. Odunsi, J. Black, P. Mhawech-Fauceglia, 2012, PloS one.

Expression profiling of the ovarian surface kinome reveals candidate genes for early neoplastic changes.

Robert L Strausberg, Samuel Levy, S. Levy, 2009, Translational oncology.

Prostate-Specific Membrane Antigen Expression Is a Potential Prognostic Marker in Endometrial Adenocarcinoma

W. Bshara, D. Smiraglia, F. Herrmann, 2008, Cancer Epidemiology Biomarkers & Prevention.

Role of the tumour necrosis family ligand APRIL in solid tumour development: Retrospective studies in bladder, ovarian and head and neck carcinomas.

F. Herrmann, K. Odunsi, A. Allal, 2008, European journal of cancer.

Phase 1 study of arsenic trioxide, high‐dose cytarabine, and idarubicin to down‐regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemia

N. Nowak, S. Sait, H. Baumann, 2011, Cancer.

Seromic profiling of ovarian and pancreatic cancer

N. Halama, D. Jäger, M. Büchler, 2010, Proceedings of the National Academy of Sciences.